Hideki Horikawa

1.7k total citations
21 papers, 1.3k citations indexed

About

Hideki Horikawa is a scholar working on Neurology, Biological Psychiatry and Developmental Neuroscience. According to data from OpenAlex, Hideki Horikawa has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 10 papers in Biological Psychiatry and 4 papers in Developmental Neuroscience. Recurrent topics in Hideki Horikawa's work include Neuroinflammation and Neurodegeneration Mechanisms (13 papers), Tryptophan and brain disorders (10 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Hideki Horikawa is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (13 papers), Tryptophan and brain disorders (10 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Hideki Horikawa collaborates with scholars based in Japan, Malaysia and United States. Hideki Horikawa's co-authors include Takahiro A. Kato, Akira Monji, Shigenobu Kanba, Yoshito Mizoguchi, Yoshihiro Seki, Sadayuki Hashioka, Yusuke Yamauchi, Shigeto Yamada, Hideo Utsumi and Kohei Hayakawa and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hideki Horikawa

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Horikawa Japan 17 630 519 301 211 207 21 1.3k
Laura Miler Canada 13 786 1.2× 444 0.9× 509 1.7× 152 0.7× 244 1.2× 13 1.4k
Yoshihiro Seki Japan 14 504 0.8× 438 0.8× 247 0.8× 152 0.7× 182 0.9× 17 983
Tina Franklin United States 9 593 0.9× 336 0.6× 389 1.3× 99 0.5× 172 0.8× 11 1.1k
Sophie Dutheil France 15 537 0.9× 415 0.8× 323 1.1× 86 0.4× 275 1.3× 20 1.4k
Madeleine Hinwood Australia 11 898 1.4× 879 1.7× 863 2.9× 100 0.5× 243 1.2× 29 1.7k
Giampaolo Milior France 12 312 0.5× 608 1.2× 227 0.8× 89 0.4× 310 1.5× 22 1.1k
Masahiro Ohgidani Japan 17 282 0.4× 344 0.7× 158 0.5× 101 0.5× 141 0.7× 39 979
S. Poggini Italy 12 412 0.7× 324 0.6× 333 1.1× 69 0.3× 171 0.8× 23 871
Ksenia Musaelyan United Kingdom 13 612 1.0× 281 0.5× 686 2.3× 117 0.6× 182 0.9× 15 1.4k
Yoshito Mizoguchi Japan 24 732 1.2× 755 1.5× 378 1.3× 310 1.5× 642 3.1× 96 2.3k

Countries citing papers authored by Hideki Horikawa

Since Specialization
Citations

This map shows the geographic impact of Hideki Horikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Horikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Horikawa more than expected).

Fields of papers citing papers by Hideki Horikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Horikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Horikawa. The network helps show where Hideki Horikawa may publish in the future.

Co-authorship network of co-authors of Hideki Horikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Horikawa. A scholar is included among the top collaborators of Hideki Horikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Horikawa. Hideki Horikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayakawa, Kohei, Motoki Watabe, Hideki Horikawa, et al.. (2022). Low-Density Lipoprotein Cholesterol Is a Possible Blood Biomarker of Schizoid Personality Traits among Females. Journal of Personalized Medicine. 12(2). 131–131. 3 indexed citations
2.
Hayakawa, Kohei, Takahiro A. Kato, Motoki Watabe, et al.. (2018). Blood biomarkers of Hikikomori, a severe social withdrawal syndrome. Scientific Reports. 8(1). 2884–2884. 45 indexed citations
3.
Sato‐Kasai, Mina, Takahiro A. Kato, Masahiro Ohgidani, et al.. (2016). Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7. Schizophrenia Research. 178(1-3). 35–43. 32 indexed citations
4.
Watabe, Motoki, Takahiro A. Kato, Alan R. Teo, et al.. (2015). Relationship between Trusting Behaviors and Psychometrics Associated with Social Network and Depression among Young Generation: A Pilot Study. PLoS ONE. 10(4). e0120183–e0120183. 16 indexed citations
5.
Mizoguchi, Yoshito, Takahiro A. Kato, Yoshihiro Seki, et al.. (2014). Brain-derived Neurotrophic Factor (BDNF) Induces Sustained Intracellular Ca2+ Elevation through the Up-regulation of Surface Transient Receptor Potential 3 (TRPC3) Channels in Rodent Microglia. Journal of Biological Chemistry. 289(26). 18549–18555. 67 indexed citations
6.
Mizoguchi, Yoshito, Takahiro A. Kato, Hideki Horikawa, & Akira Monji. (2014). Microglial intracellular Ca2+ signaling as a target of antipsychotic actions for the treatment of schizophrenia. Frontiers in Cellular Neuroscience. 8. 370–370. 24 indexed citations
7.
Seki, Yoshihiro, Takahiro A. Kato, Akira Monji, et al.. (2013). Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model. Schizophrenia Research. 151(1-3). 20–28. 58 indexed citations
8.
Kato, Takahiro A., Yusuke Yamauchi, Hideki Horikawa, et al.. (2013). Neurotransmitters, Psychotropic Drugs and Microglia: Clinical Implications for Psychiatry. Current Medicinal Chemistry. 20(3). 331–344. 59 indexed citations
9.
Isomura, Shuichi, Akira Monji, Kensuke Sasaki, et al.. (2013). FTD with catatonia-like signs that temporarily resolved with zolpidem. Neurology Clinical Practice. 3(4). 354–357. 14 indexed citations
10.
Mizoguchi, Yoshito, Akira Monji, Takahiro A. Kato, et al.. (2011). Possible Role of BDNF-Induced Microglial Intracellular Ca<sup>2+</sup> Elevation in the Pathophysiology of Neuropsychiatric Disorders. Mini-Reviews in Medicinal Chemistry. 11(7). 575–581. 14 indexed citations
11.
Watabe, Motoki, Takahiro A. Kato, Akira Monji, Hideki Horikawa, & Shigenobu Kanba. (2011). Does minocycline, an antibiotic with inhibitory effects on microglial activation, sharpen a sense of trust in social interaction?. Psychopharmacology. 220(3). 551–557. 25 indexed citations
12.
Kato, Takahiro A., Akira Monji, Yoshito Mizoguchi, et al.. (2011). Anti-Inflammatory Properties of Antipsychotics Via Microglia Modulations: Are Antipsychotics a &#x2018;Fire Extinguisher&#x2019; in the Brain of Schizophrenia?. Mini-Reviews in Medicinal Chemistry. 11(7). 565–574. 107 indexed citations
13.
Kato, Takahiro A., Akira Monji, Keiji Yasukawa, et al.. (2011). Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: Implication for antioxidative psychotropic actions via microglia. Schizophrenia Research. 129(2-3). 172–182. 50 indexed citations
14.
Monji, Akira, Takahiro A. Kato, Yoshito Mizoguchi, et al.. (2011). Neuroinflammation in schizophrenia especially focused on the role of microglia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 42. 115–121. 259 indexed citations
15.
Horikawa, Hideki, Takahiro A. Kato, Yoshito Mizoguchi, et al.. (2010). Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(7). 1306–1316. 96 indexed citations
16.
Mizoguchi, Yoshito, Akira Monji, Takahiro A. Kato, et al.. (2009). Brain-Derived Neurotrophic Factor Induces Sustained Elevation of Intracellular Ca2+ in Rodent Microglia. The Journal of Immunology. 183(12). 7778–7786. 52 indexed citations
17.
Kato, Takahiro A., Yoshito Mizoguchi, Akira Monji, et al.. (2008). Inhibitory effects of aripiprazole on interferon‐γ‐induced microglial activation via intracellular Ca2+ regulation in vitro. Journal of Neurochemistry. 106(2). 815–825. 101 indexed citations
18.
Monji, Akira, et al.. (2008). Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(2). 308–311. 86 indexed citations
19.
Bian, Qian, Takahiro A. Kato, Akira Monji, et al.. (2007). The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-γ. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(1). 42–48. 130 indexed citations
20.
Horikawa, Hideki, Akira Monji, Masayuki Sasaki, et al.. (2006). Different SPECT findings before and after Capgras’ syndrome in interictal psychosis. Epilepsy & Behavior. 9(1). 189–192. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026